Many Americans won't benefit from Eli Lilly's insulin price cut

When drugmaker Eli Lilly announced it was slashing the cost of insulin and capping out-of-pocket costs to just $35 a month, it was major news.

Related Keywords

United States , California , Washington , Americans , Michael Greiner , Nicole Gambino , Eli Lilly , Brandon Karmo , Oakland University , Greiner , Novo Nordisk ,